| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,812 |
18,470 |
$1.33M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,356 |
15,873 |
$945K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13,384 |
11,929 |
$526K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,366 |
7,347 |
$472K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,398 |
3,393 |
$305K |
| 86769 |
|
1,632 |
756 |
$50K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,502 |
1,775 |
$45K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,023 |
5,123 |
$45K |
| 99058 |
|
635 |
573 |
$40K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,705 |
1,684 |
$20K |
| 99001 |
|
774 |
747 |
$6K |
| 81002 |
|
2,543 |
2,451 |
$5K |
| 99215 |
Prolong outpt/office vis |
60 |
56 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,086 |
1,888 |
$2K |
| 73130 |
|
82 |
80 |
$2K |
| 73630 |
|
91 |
89 |
$1K |
| 87807 |
|
130 |
129 |
$1K |
| 73610 |
|
56 |
55 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,417 |
1,324 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,461 |
2,030 |
$983.67 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,824 |
3,342 |
$280.12 |
| 81025 |
|
12 |
12 |
$71.30 |
| A6448 |
Light compression bandage, elastic, knitted/woven, width less than three inches, per yard |
12 |
12 |
$1.04 |
| 99072 |
|
6,537 |
5,798 |
$0.00 |
| 99051 |
|
496 |
471 |
$0.00 |